Developer docs
API playgroundTry for free, no card

Search company profiles

Medtech SAS

Full company profile

uuid0035ksv

Namestring
Medtech SAS
Legal namestring
Medtech SAS
Websiteurl
medtech.fr
Company typeenum
Private
Founded yearint
2002
Descriptiontext

Medtech SAS is a French medical device company, founded in 2002 and headquartered in Le Lez, France, that designs, develops, and markets robotic assistance systems intended to enable improved surgical techniques, with a focus on minimally invasive procedures (per firmographics). The company operates in the surgical robotics category, competing alongside Intuitive Surgical, Stryker Corporation, and Medtronic, and its former Euronext Paris ticker (epa:ROSA, now delisted) indicates that the ROSA robotic platform is its flagship product. The company's primary end customers are hospitals, where its systems are deployed to support robotic-assisted surgery, improved precision, reduced patient recovery times, and minimally invasive surgical workflows. Operating geographies span North America and Europe, positioning Medtech within the two largest regional surgical robotics markets globally.

The business model centers on the sale and support of high-capital robotic systems to hospital customers, with the company employing between 251 and 500 people (per firmographics). Pricing models, distribution channels, marketing channels, and specific revenue mechanics are not publicly disclosed in available sources (per firmographics), though the category typically involves capital hardware sales paired with recurring service contracts and consumable revenue. Funding history is limited to a single disclosed round on 2010-04-23: approximately USD 2 million in Series 2 financing led by Newfund. The company has operated as a publicly listed entity (Euronext Paris, epa:ROSA) and is currently flagged as delisted, indicating a transition from public market status without disclosed recent ownership or strategic context in the input material.

The broader market context is favorable: the US surgical robotics market is projected to grow from USD 6.60 billion in 2025 to USD 16.89 billion by 2033 at an 11.3% CAGR, and the European market is projected to grow from USD 3.88 billion in 2024 to USD 23.97 billion by 2033 at a 22.42% CAGR. North America holds 47.6% of the US surgical robotics market share, while Intuitive Surgical holds 38.6% share of the broader competitive set including Medtech. Customer segmentation is vertical (hospitals), with the value proposition centered on enabling minimally invasive procedures, supporting healthcare infrastructure modernization, and addressing the growing demand for precision surgical technology. Specific products, certifications, partnerships, management team, and detailed financial metrics are not disclosed in the available source material, leaving significant gaps in company-specific visibility despite clear market positioning.

Short descriptiontext

Medtech SAS is a French medical device company, founded in 2002, that designs and markets robotic assistance systems for minimally invasive surgery. The company serves hospital customers across North American and European markets in the surgical robotics category.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersLe Lez, France
HQ citystring
Le Lez
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
surgical robotics, robotic-assisted surgery, minimally invasive surgery, medical robotics, surgical assistance systems
Industry5 codes
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHAEAL
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHADAG
Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHDAAAIAC
Healthcare & Assistive Robotics
SECONDARYHLAHADAE
Operating Room Integration & Surgical Informatics (OR control, documentation, connectivity)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Surgical Robotics
Cost components4 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Medtech SAS designs, develops and markets a new generation of robotic assistance systems aimed at improving surgical techniques. The company's offering targets hospitals performing minimally invasive procedures, providing precision in surgical tasks and supporting reduced patient recovery times as part of advanced healthcare infrastructure.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Robotic surgical assistance systems
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Offers the Hugo robotic-assisted surgery platform; competes head-to-head with Medtech ROSA in soft-tissue and laparoscopic procedures and is explicitly identified as a key player alongside Medtech.

TypeDirect peer
Description

Operates in surgical robotics and robotic-assisted orthopaedic procedures with its CORI platform; competes with Medtech for hospital capital budgets and minimally invasive surgery indications.

TypeDirect peer
Description

Markets the ExcelsiusGPS robotic navigation and guidance platform, most directly competitive with ROSA in spine surgery and overlapping in surgical-navigation customer segments.

TypeEmerging player
Description

Developer of surgical navigation, image-guided surgery and increasingly robotic-assisted platforms; comparable to Medtech in neurosurgery and spine, with overlapping image-guided intraoperative technology.

TypeBroad incumbent
Description

Large orthopaedic medtech incumbent that acquired Medtech SAS; comparable as both a buyer of surgical-robotics technology and a competitor in orthopaedic surgical robotics via its ROSA-integrated portfolio.

TypeDirect peer
Description

Markets the Mako robotic-assisted surgery system primarily for orthopaedics; competes with Medtech's ROSA in spine and adjacent surgical specialties and is named alongside Medtech as a key industry player.

TypeBroad incumbent
Description

Large imaging-and-interventional-care incumbent integrating robotics, navigation and surgical informatics; comparable to Medtech as a broader platform player crossing imaging, navigation and OR integration.

TypeEmerging player
Description

Provides neurosurgical robotic systems (e.g., Neuromate) and surgical navigation instruments; comparable to Medtech in image-guided neurosurgery and adjacent robotic-assisted procedures.

TypeDirect peer
Description

Global leader in surgical robotics with the da Vinci platform; directly comparable to Medtech as a robotic-assisted minimally invasive surgery vendor competing for the same hospital customers and surgical indications.

TypeBroad incumbent
Description

Through Ethicon/MedTech and the Verb Surgical initiative, J&J is developing soft-tissue surgical robotics; competes broadly with Medtech as a large diversified medtech investing aggressively in robotic-assisted surgery.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Medtech SAS

Surgical Roboticsmedtech.fr

Medtech SAS is a French medical device company, founded in 2002, that designs and markets robotic assistance systems for minimally invasive surgery. The company serves hospital customers across North American and European markets in the surgical robotics category.

What Medtech SAS does

Medtech SAS is a French medical device company, founded in 2002 and headquartered in Le Lez, France, that designs, develops, and markets robotic assistance systems intended to enable improved surgical techniques, with a focus on minimally invasive procedures (per firmographics). The company operates in the surgical robotics category, competing alongside Intuitive Surgical, Stryker Corporation, and Medtronic, and its former Euronext Paris ticker (epa:ROSA, now delisted) indicates that the ROSA robotic platform is its flagship product. The company's primary end customers are hospitals, where its systems are deployed to support robotic-assisted surgery, improved precision, reduced patient recovery times, and minimally invasive surgical workflows. Operating geographies span North America and Europe, positioning Medtech within the two largest regional surgical robotics markets globally.

The business model centers on the sale and support of high-capital robotic systems to hospital customers, with the company employing between 251 and 500 people (per firmographics). Pricing models, distribution channels, marketing channels, and specific revenue mechanics are not publicly disclosed in available sources (per firmographics), though the category typically involves capital hardware sales paired with recurring service contracts and consumable revenue. Funding history is limited to a single disclosed round on 2010-04-23: approximately USD 2 million in Series 2 financing led by Newfund. The company has operated as a publicly listed entity (Euronext Paris, epa:ROSA) and is currently flagged as delisted, indicating a transition from public market status without disclosed recent ownership or strategic context in the input material.

The broader market context is favorable: the US surgical robotics market is projected to grow from USD 6.60 billion in 2025 to USD 16.89 billion by 2033 at an 11.3% CAGR, and the European market is projected to grow from USD 3.88 billion in 2024 to USD 23.97 billion by 2033 at a 22.42% CAGR. North America holds 47.6% of the US surgical robotics market share, while Intuitive Surgical holds 38.6% share of the broader competitive set including Medtech. Customer segmentation is vertical (hospitals), with the value proposition centered on enabling minimally invasive procedures, supporting healthcare infrastructure modernization, and addressing the growing demand for precision surgical technology. Specific products, certifications, partnerships, management team, and detailed financial metrics are not disclosed in the available source material, leaving significant gaps in company-specific visibility despite clear market positioning.

Medtech SAS firmographics

Firmographics
Name
Medtech SAS
Legal name
Medtech SAS
Website
https://medtech.fr
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
251–500 employees
Short description
Medtech SAS is a French medical device company, founded in 2002, that designs and markets robotic assistance systems for minimally invasive surgery. The company serves hospital customers across North American and European markets in the surgical robotics category.
Ownership category
akta.pro rank

Medtech SAS industry classification

Industry
Product category
Surgical Robotics
NAICS
Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHAEAL
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHADAG
Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHDAAAIAC
Healthcare & Assistive Robotics
SECONDARYHLAHADAE
Operating Room Integration & Surgical Informatics (OR control, documentation, connectivity)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment

Keywords

  • Surgical robotics
  • Robotic-assisted surgery
  • Minimally invasive surgery
  • Medical robotics
  • Surgical assistance systems

Where Medtech SAS is headquartered

Location

Headquarters

HQ city
Le Lez
HQ country
France
HQ region
Europe

Markets served

Medtech SAS business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales

Medtech SAS product offering

Product offering

Core offering

Medtech SAS designs, develops and markets a new generation of robotic assistance systems aimed at improving surgical techniques. The company's offering targets hospitals performing minimally invasive procedures, providing precision in surgical tasks and supporting reduced patient recovery times as part of advanced healthcare infrastructure.

Differentiator

Problem solved

Functional benefit

Products and services

  • Robotic surgical assistance systems

Companies that use Medtech SAS

Customer profile

Segments1 record

Ideal customer profiles1 record

Medtech SAS technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Medtech SAS partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves3 records

Expansion highlights3 records

Medtech SAS competitors and assessment

Company assessment

Direct peers

  • Medtronic: Offers the Hugo robotic-assisted surgery platform; competes head-to-head with Medtech ROSA in soft-tissue and laparoscopic procedures and is explicitly identified as a key player alongside Medtech.
  • Smith+Nephew: Operates in surgical robotics and robotic-assisted orthopaedic procedures with its CORI platform; competes with Medtech for hospital capital budgets and minimally invasive surgery indications.
  • Globus Medical: Markets the ExcelsiusGPS robotic navigation and guidance platform, most directly competitive with ROSA in spine surgery and overlapping in surgical-navigation customer segments.
  • Stryker Corporation: Markets the Mako robotic-assisted surgery system primarily for orthopaedics; competes with Medtech's ROSA in spine and adjacent surgical specialties and is named alongside Medtech as a key industry player.
  • Intuitive Surgical: Global leader in surgical robotics with the da Vinci platform; directly comparable to Medtech as a robotic-assisted minimally invasive surgery vendor competing for the same hospital customers and surgical indications.

Emerging players

  • Brainlab: Developer of surgical navigation, image-guided surgery and increasingly robotic-assisted platforms; comparable to Medtech in neurosurgery and spine, with overlapping image-guided intraoperative technology.
  • Renishaw: Provides neurosurgical robotic systems (e.g., Neuromate) and surgical navigation instruments; comparable to Medtech in image-guided neurosurgery and adjacent robotic-assisted procedures.

Broad incumbents

  • Zimmer Biomet: Large orthopaedic medtech incumbent that acquired Medtech SAS; comparable as both a buyer of surgical-robotics technology and a competitor in orthopaedic surgical robotics via its ROSA-integrated portfolio.
  • Siemens Healthineers: Large imaging-and-interventional-care incumbent integrating robotics, navigation and surgical informatics; comparable to Medtech as a broader platform player crossing imaging, navigation and OR integration.
  • Johnson & Johnson (MedTech / Verb Surgical): Through Ethicon/MedTech and the Verb Surgical initiative, J&J is developing soft-tissue surgical robotics; competes broadly with Medtech as a large diversified medtech investing aggressively in robotic-assisted surgery.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Medtech SAS social profiles

Digital presence

Medtech SAS financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Medtech SAS leadership team

Management profile

Number of profiles

Medtech SAS funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Medtech SAS M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medtech SAS

What does Medtech SAS do?

Medtech SAS designs, develops and markets a new generation of robotic assistance systems aimed at improving surgical techniques. The company's offering targets hospitals performing minimally invasive procedures, providing precision in surgical tasks and supporting reduced patient recovery times as part of advanced healthcare infrastructure.

When was Medtech SAS founded?

Medtech SAS was founded in 2002. It employs 251 to 500 people.

Where is Medtech SAS based?

Medtech SAS is headquartered in Le Lez, France, in the Europe region.

Who are Medtech SAS's main competitors?

Direct peers on record are Medtronic, Smith+Nephew, Globus Medical, Stryker Corporation and Intuitive Surgical. Emerging players are Brainlab and Renishaw. Broad incumbents are Zimmer Biomet, Siemens Healthineers and Johnson & Johnson (MedTech / Verb Surgical).

Does Medtech SAS have an API?

No public API is recorded for Medtech SAS.

What industry is Medtech SAS in?

Medtech SAS's product category is Surgical Robotics. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAHAEAL, Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireZimmer Biomet Reports Third Quarter 2016 Financial ResultsZimmer Biomet Holdings, Inc. reported third quarter 2016 financial results with net sales of $1.83 billion, a 4.0% increase over the prior year period, and adjusted constant currency revenue growth of 3.5%. Diluted earnings per share were $0.78, representing a 609.1% increase year-over-year, while adjusted diluted EPS reached $1.79, up 9.1%. During the quarter, the company completed three strategic acquisitions—LDR Holding Corporation, CD Diagnostics, and Medtech SA—to expand its musculoskeletal and robotics offerings.GlobeNewswireMEDTECH to Showcase Its ROSA Robot at Three Major International CongressesMEDTECH will showcase its ROSA robot at three major neurosurgery congresses in September: EANS in Athens, CNS in San Diego, and ESSFN in Madrid. Presentations by neurosurgeons will cover robotic accuracy and minimally invasive procedures. The company also highlights its ROSA Spine product with FDA clearance.GlobeNewswireMEDTECH Fiscal 2016 Revenue Increases 73% to €11.2 MillionMEDTECH reported fiscal 2016 revenue of €11.2 million, a 73% increase year-over-year. Its installed base of ROSA robots grew to 82, up from 48, with 34 sold in the year. Cash available at June 30, 2016 was €17.9 million.MedCity NewsZimmer finally gets into robotics game with French dealZimmer Biomet announced it will buy 58.8% of French surgical robotics maker Medtech SA, paying 50 euros per share. The company plans an all-cash offer for the remaining shares, and Medtech's CEO will lead robotic development under Zimmer.GlobeNewswireMEDTECH Announces the Sale of Thirteen New ROSA Robots in Fiscal Fourth Quarter 2016MEDTECH announced the sale of 13 ROSA robots in fiscal Q4 2016, with 7 in the US, 2 in France, 2 in China, 1 in Germany, and 1 in England. This exceeds the 10 sold in the same period the prior year, bringing total 2016 sales to 33 versus 20 in 2015.GlobeNewswireMedtech Announces Six New Global Sales of ROSA Brain RobotMedtech announced six new sales of its ROSA Brain robot, with two in the US, two in China, one in England, and one in France. The company now has 11 ROSA Brain robots in China. Q4 2016 sales and annual revenue for the fiscal year ending June 30, 2016, will be released in July.GlobeNewswireMedtech’s ROSA Robot to be Featured at Three MajorMedtech announced it will showcase its ROSA surgical robot at three major neurosurgery congresses in June: SFCR in Lyon, DGNC in Frankfurt, and ASSFN in Chicago. Presentations will cover clinical results from spine and brain surgeries, with the company highlighting its European and FDA-approved devices.GlobeNewswireMEDTECH Announces First ROSA Spine Surgery in SpainMEDTECH announced the first ROSA Spine surgery in Spain, performed at Hospital La Fe in Valencia on a 47-year-old patient with degenerative disc disease. The procedure fused lumbar vertebrae to reduce back pain, and the company noted growing adoption of its robotic technology in Europe.GlobeNewswireMEDTECH Achieves 100th ROSA Spine Surgery MilestoneMEDTECH announced that 100 spinal surgeries have been performed with its ROSA Spine robotic-assistive device. The 100th case was performed by Dr. Michel Lefranc, and the device received CE Mark in 2014 and FDA clearance in January 2016. CEO Bertin Nahum said the milestone validates the technology's potential in the spine market.GlobeNewswireMEDTECH Announces First ROSA Spine Surgery in the United StatesMEDTECH announced the first U.S. ROSA Spine surgery at Miami Valley Hospital in Dayton, Ohio, performed by Dr. Juan Torres-Reveron. The device received FDA clearance in January 2016, and the hospital was the first U.S. site to acquire it.